Pembrolizumab+chemotherapy as first-line treatment in patients with HER negative advanced oesogastric adenocarcinoma

Bull Cancer. 2024 Mar 7:S0007-4551(24)00072-9. doi: 10.1016/j.bulcan.2024.01.004. Online ahead of print.NO ABSTRACTPMID:38458924 | DOI:10.1016/j.bulcan.2024.01.004

Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Martin Duval Aziz Zaanan Source Type: research